Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway.
Walaa Yehia AbdelzaherGomaa Mostafa-HedeabHaitham Ahmed BahaaAhmad MahranMichael Atef FawzySara Mohamed Naguib Abdel HafezNermeen N WelsonRemon Roshdy RofaeilPublished in: Pharmaceuticals (Basel, Switzerland) (2022)
Mont exerted the biochemical and histopathological amelioration of L-NAME-caused pre-eclampsia through its anti-inflammatory, anti-oxidant function and suppression of the IL-6/Jak2/STAT3 signaling pathway.